1291. PROVE (Retrospective Cefiderocol Chart Review) Study of Real-World Outcomes and Safety in the Treatment of Patients with Gram-negative Bacterial Infections in the US and Europe

BACKGROUND: Gram-negative bacterial resistance is a global health problem. Limited treatment options exist, especially for carbapenem resistant (CR) pathogens containing metallo-β-lactamases (MBLs) and multidrug resistant non-lactose fermenting bacteria. Cefiderocol (CFDC) retains activity against r...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcella, Stephen, Chopra, Teena, Vazquez, Jose A, Smoke, Steven, Shields, Ryan K, van Duin, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644329/
http://dx.doi.org/10.1093/ofid/ofab466.1483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644329/
http://dx.doi.org/10.1093/ofid/ofab466.1483

Ejemplares similares